Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
Open accessThe DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Our objective was to evaluate the published literature and reach a consensus on the treatment of patients with ACTH-dependent Cushing's syndrome, because there is no recent consensus on the management of this rare disorder. PARTICIPANTS: Thirty-two leading endocrinologists, clinicians, and neurosurgeons with specific expertise in the management of ACTH-dependent Cushing's syndrome representing nine countries were chosen to address 1) criteria for cure and remission of this disorder, 2) surgical treatment of Cushing's disease, 3) therapeutic options in the event of persistent disease after transsphenoidal surgery, 4) medical therapy of Cushing's disease, and 5) management of ectopic ACTH syndrome, Nelson's syndrome, and special patient populations. EVIDENCE: Participants presented published scientific data, which formed the basis of the recommendations. Opinion shared by a majority of experts was used where strong evidence was lacking. CONSENSUS PROCESS: Participants met for 2 d, during which there were four chaired sessions of presentations, followed by general discussion where a consensus was reached. The consensus statement was prepared by a steering committee and was then reviewed by all authors, with suggestions incorporated if agreed upon by the majority. CONCLUSIONS: ACTH-dependent Cushing's syndrome is a heterogeneous disorder requiring a multidisciplinary and individualized approach to patient management. Generally, the treatment of choice for ACTH-dependent Cushing's syndrome is curative surgery with selective pituitary or ectopic corticotroph tumor resection. Second-line treatments include more radical surgery, radiation therapy (for Cushing's disease), medical therapy, and bilateral adrenalectomy. Because of the significant morbidity of Cushing's syndrome, early diagnosis and prompt therapy are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As with Cushing’s disease, it may be helpful to use a cortisol synthesis blocking drug while waiting for definitive treatment (18) and in cases where definitive treatment is not possible.”
From ACTH Antagonists (2016) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Once a diagnosis is conclusively made, the optimal treatment is surgical removal of the tumor – ideally preserving the remaining pituitary function.”
From ACTH Antagonists (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362 · cited 3×
“excess cortisol secretion by unilateral adrenocortical tumors or by bilateral adrenal hyperplasia or dysplasia (1).”
BackgroundInfluentialSelf-citationValvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease
Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., & Pezzoli, G. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa054830 · Cited by 884 · cited 1×
“However, more data are required not only for efficacy but also to address the long-term safety of cabergoline in these patients (84, 85).”
BackgroundThe Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
Self-citationDopamine Agonists and the Risk of Cardiac-Valve Regurgitation
Schade, R., Andersohn, F., Suissa, S., Haverkamp, W., & Garbe, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062222 · Cited by 718
Ilias, I., Torpy, D. J., Pacak, K., Mullen, N., Wesley, R. A., & Nieman, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2527 · Cited by 713
Self-citationBruns, C., Lewis, I., Briner, U., Meno-Tetang, G., & Weckbecker, G. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460707 · Cited by 692
Isidori, A. M., Kaltsas, G. A., Pozza, C., Frajese, V., Newell-Price, J., Reznek, R. H., Jenkins, P. J., Monson, J. P., Grossman, A. B., & Besser, G. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1542 · Cited by 522
Self-citationThe hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment
Lindsay, J. R., & Nieman, L. K. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0025 · Cited by 449 · cited 1×
“Detection of Cushing’s syndrome usually occurs late in gestation, and the diagnosis is complicated by the signs of normal pregnancy, such as central weight gain, facial plethora, and pigmentation (101) and the normal physiological changes in the maternal HPA axis.”
BackgroundSelf-citationPosterior retroperitoneoscopic adrenalectomy–results of 560 procedures in 520 patients
Walz, M. K., Alesina, P. F., Wenger, F. A., Deligiannis, A., Szuczik, E., Petersenn, S., Ommer, A., Groeben, H., Peitgen, K., Janssen, O. E., et al. (2006) · Surgery · doi:10.1016/j.surg.2006.07.039 · Cited by 425
Self-citationRisk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.
Brada, M., Ford, D., Ashley, S., Bliss, J. M., Crowley, S., Mason, M., Rajan, B., & Traish, D. (1992) · BMJ · doi:10.1136/bmj.304.6838.1343 · Cited by 413 · cited 1×
“The risk of second tumor formation after pituitary radiation is considered to be in the range of 1–2% (39), but this may not be due to the radiotherapy per se.”
Background
Research works printed but not linked: 1
- 52. Sonino N, Boscaro M, Ambroso G, Merola G, Mantero F 1986 Prolonged - treatment of Cushing's disease with metyrapone and aminoglutethimide. IRCS Med Sci 14:485-486
Cited by
Items 601–700 of 863
Consensus-driven in-hospital cortisol assessment after ACTH-secreting pituitary adenoma resection
Stolyarov, Y., Mirocha, J., Mamelak, A. N., & Ben-Shlomo, A. (2017) · Pituitary · doi:10.1007/s11102-017-0845-3 · Cited by 3
Adrenal Cortical Nodular Hyperplasia
Lotfollahzadeh, S., & Taherian, M. (2020) · StatPearls · Cited by 3
Presurgical predictive factors of surgical remission in Cushing's disease. Study of 32 cases
Castro, M. A., Pinedo, M. M., Fernández-Argüeso, M., Pérez, M. P., Ruiz, E. B., Pian, H. G., Berrocal, V. R., & Corrales, E. P. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.07.004 · Cited by 5
Presurgical predictive factors of surgical remission in Cushing's disease. Study of 32 cases
Castro, M. A., Pinedo, M. M., Fernández-Argüeso, M., Pérez, M. P., Ruiz, E. B., Pian, H. G., Berrocal, V. R., & Corrales, E. P. (2022) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2021.07.003 · Cited by 3
Sun, H., Wu, C., Hu, B., & Xiao, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1238573 · Cited by 3
Sjoeholm, A., Li, C., Leem, C., Lee, A., Stack, M. P., Hofman, P. L., & Wheeler, B. J. (2015) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-15-0041 · Cited by 3
Trastornos de la glándula suprarrenal: diagnóstico y tratamiento
Verónica, Q. A. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70222-0 · Cited by 7
“En la última década, algunos autores han propuesto no utilizar las pruebas funcionales, porque han encontrado un porcentaje no despreciable de falsos positivos y negativos y recomiendan directamente realizar una resonancia nuclear magnética (RNM) de silla turca y, si esta es negativa o dudosa, realizar un cateterismo…”
Aktaş, G. E., Demir, S. S., & Sarıkaya, A. (2015) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2015.08.011 · Cited by 3
Ophthalmic manifestations of endocrine disorders: approaches and medical management
Hendrick, A. M., Kahook, M. Y., Daoud, Y. J., & Hazin, R. (2009) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e328331903c · Cited by 4
Recent Developments in Drug Therapy for Cushing’s Disease
van der Pas, R., de Herder, W. W., Hofland, L. J., & Feelders, R. A. (2013) · Drugs · doi:10.1007/s40265-013-0067-6 · Cited by 4
“Optimal medical therapy for CD would permanently normalize ACTH and cortisol production, reverse morbidity and mortality, improve quality of life, and control or reduce tumor growth in case of a macroadenoma [12].”
BackgroundInfluentialSelf-citationValego, N. K., & Rose, J. C. (2010) · Reproductive Sciences · doi:10.1177/1933719110361959 · Cited by 3
Treatment of canine and feline hyperadrenocorticism: trilostane and the alternatives
Scudder, C., Kenny, P. J., & Niessen, S. (2015) · Companion animal · doi:10.12968/coan.2015.20.4.230 · Cited by 3
Update on Hypercortisolism Therapy
Arnaldi, G., & Trementino, L. (2016) · Frontiers of hormone research · doi:10.1159/000443869 · Cited by 3
A survey of clinical practice patterns in diagnosis and management of Cushing's disease in Iran.
Malek, M., Esfehanian, F., Amouzegar, A., Sarvghadi, F., Moosavi, Z., Mohajeri‐Tehrani, M. R., Khamseh, M. E., Amirbaigloo, A., & Valojerdi, A. E. (2016) · PubMed Central · Cited by 4
Endocrine Hypertensive Emergencies
Eisenhofer, G., Januszewicz, A., Pamporaki, C., & Lenders, J. W. M. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch22 · Cited by 3
Cushing Syndrome: Presentation, Diagnosis, and Treatment, Including Subclinical Cushing Syndrome
Neychev, V. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_9 · Cited by 3
Nelson Syndrome: A Case Report and Literature Review
Salazar, F. E., González, J. A. H., Toledo, A. R. L., Abraham, D. I., Corral, A., Armenta-Moreno, J. I., Vargas-Abonce, V. P., Ramos, D. C., Gomez-Perez, F. J., & Gómez-Sámano, M. Á. (2020) · AACE Clinical Case Reports · doi:10.1016/j.aace.2020.11.034 · Cited by 3
Morning Serum Cortisol as a Predictor for the HPA Axis Recovery in Cushing’s Disease
Cui, Q., Liu, D., Xiang, B., Sun, Q., Fan, L., He, M., Wang, Y., Zhu, X., & Ye, H. (2021) · International Journal of Endocrinology · doi:10.1155/2021/4586229 · Cited by 3
Pituitary disease in pregnancy
Dworakowska, D., & Aylwin, S. J. B. (2012) · Series in maternal-fetal medicine · doi:10.3109/9781841847597.018 · Cited by 3
Castinetti, F., Graillon, T., Dufour, H., & Brue, T. C. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01183 · Cited by 3
Outcome squares integrating efficacy and safety, as applied to functioning pituitary adenoma surgery
de, V. F., Lobatto, D. J., Verstegen, M. J. T., Schutte, P. J., Notting, I. C., Kruit, M. C., Ahmed, F., Pereira, A. M., van Furth, W. R., & Biermasz, N. R. (2020) · Endocrine Abstracts · doi:10.1530/endoabs.70.aep1076 · Cited by 3
“The main efficacy parameter was biochemical remission according to published guidelines (9-12, 14-16).”
MethodSurgical Treatment of Cushing’s Disease: The Lessons Learned
de Nijs, L., Fomekong, E., Maiter, D. M., & Raftopoulos, C. (2025) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-031-90762-3_3 · Cited by 2
Pokrzywa, A., Pachucki, J., Bobrowicz, M., Koperski, Ł., & Ambroziak, U. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1649633 · Cited by 2
“Less commonly, ectopic ACTH production is identi fi ed, occurring in approximately 10-20% of patients (4, 5).”
Alexandraki, K., Isidori, A. M., & Grossman, A. B. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-449-4_14 · Cited by 3
Self-citationEctopic ACTH syndrome – Experience with Etomidate*
Tong, C. V., & Hussein, Z. B. (2017) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.032.01.10 · Cited by 2
Adenomas funcionantes de la hipófisis
Carrera, C. B., Fernández-Fernández, C., & Taioli, P. E. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.06.020 · Cited by 4
Medical management of Cushing's disease
Kelsall, A., & Newell-Price, J. D. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819949-7.00046-9 · Cited by 3
Self-citationRecurrent Neuroendocrine Tumor of the Cervix Presenting With Ectopic Cushing’s Syndrome
Rico, J. G., Zgheib, N. B., Pramrod, S., & Olajide, O. B. (2022) · Cureus · doi:10.7759/cureus.31541 · Cited by 2
“We initially chose mifepristone because it is indicated in patients with type 2 diabetes mellitus and could be given safely despite the patient’s worsening liver function levels [11].”
MethodCastillo-Huerta, N. M., de la Cruz, J. I. C., Quispe-Gárate, L. A., Lévano-Martínez, M. A., Cabrera, B. M., & Sheen, E. C. (2023) · Surgical Neurology International · doi:10.25259/sni_64_2023 · Cited by 2
“Surgical Neurology International • 2023 • 14(123) | 8 without recurrence.[4] Remission is generally defined as morning serum cortisol values <5 μg/dL (<138 nmoL/L) or UFC <28–56 nmoL/d (<10–20 μg/day) within 7 days of adenomectomy.”
BackgroundBone mineral density in patients with Cushing’s syndrome
Seker, A., & Yavuz, D. G. (2024) · Marmara medical journal · doi:10.5472/marumj.1485351 · Cited by 2
Ravnik, J., Rowbottom, H., Snyderman, C. H., Gardner, P. A., Šmigoc, T., Glavan, M., Ksela, U., Kljaić, N., & Lanišnik, B. (2024) · Diagnostics · doi:10.3390/diagnostics14171874 · Cited by 2
“Treatment aims to reduce hormone hypersecretion, remove the mass effect, and correct hormone deficiency [22–24].”
BackgroundMethodPituitary Tumors and Craniopharyngiomas
Suh, J. H., Chao, S. T., Murphy, E. S., & Weil, R. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24098-7.00029-0 · Cited by 3
BERTAGNA, X. Y., Guignat, L., Raux-Demay, M. C., Guilhaume, B., & Girard, F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10016-1 · Cited by 5
Self-citationPan, B., Song, Y. J., Kong, X., Xue, Z., & Guo, Y. (1998) · PubMed · Cited by 2
Zada, G., Woodmansee, W. W., Kaiser, U. B., & Laws, E. R. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-166-0_16 · Cited by 2
Maladie de Cushing à imagerie négative chez l’adulte
Philippon, M., Castinettia, F., & Brue, T. C. (2013) · Annales d Endocrinologie · doi:10.1016/s0003-4266(13)70018-0 · Cited by 3
Traitement de la maladie de Cushing : progrès récents
BERTAGNA, X. Y., & Guignat, L. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.03.036 · Cited by 2
“[4] Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, et al.”
Self-citationSanguin, F., Albiger, N. M. E., Betterle, C., Mian, C., Gatti, R., Rossi, E., Mantero, F., & Scaroni, C. M. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346634 · Cited by 2
An ACTH-secreting Pituitary Adenoma Within the Sphenoid Sinus
Suzuki, K., Hattori, Y., Aoki, C., Nakano, A., Tomizawa, A., Kase, H., & Kasai, K. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.2477 · Cited by 2
Modeling the interactions between MC2R and ACTH models from human
Mutangana, D., & Ramesh, K. V. (2014) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2014.910475 · Cited by 2
Actualités thérapeutiques dans la prise en charge médicale des adénomes hypophysaires
Drutel, A., Caron, P. J., & Archambeaud, F. (2008) · Annales d Endocrinologie · doi:10.1016/s0003-4266(08)73964-7 · Cited by 2
Radioterapia nos tumores da hipófise - atualizações e controvérsias
Moreno, C., Paiva, I., Gomes, L., Ruas, L., & Carvalheiro, M. C. (2013) · Endocrinology Insights · doi:10.26497/2013.000005.000338 · Cited by 4
Störungen der Nebennierenfunktion bei Kindern und Jugendlichen
Partsch, C., & Riepe, F. G. (2015) · Springer eBooks · doi:10.1007/978-3-642-54671-6_90-1 · Cited by 2
Marko, N. F., & Weil, R. J. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511997426.056 · Cited by 2
Dr. Dhiman, A., & Kar, S. K. (2015) · La Prensa Medica · doi:10.4172/lpma.1000176 · Cited by 2
Carmalt, J. L., Duke‐Novakovski, T., Schott, H. C., & van der Kolk, J. H. (2016) · American Journal of Veterinary Research · doi:10.2460/ajvr.77.7.730 · Cited by 2
Sex Hormone, Pituitary, Parathyroid, and Adrenal Disorders and the Nervous System
Schipper, H. M., Jay, C. A., & Abrams, G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407710-2.00020-5 · Cited by 3
Cushing’s Disease, Refining the Definition of Remission and Recurrence
Ciporen, J. N., Cetas, J. S., McCartney, S., & Fleseriu, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_12 · Cited by 2
Matheny, L. N., Sarkar, S., Shi, H., Hu, J., Harmsen, H. J., Abel, T. W., Jagasia, S. M., & Bao, S. (2018) · Case Reports in Endocrinology · doi:10.1155/2018/6389374 · Cited by 2
Hypothalamic, pituitary and adrenal disorders
Levy, M. J., & Howlett, T. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-7020-5140-1.00018-3 · Cited by 4
Clinical aspects of endocrinology: parathyroid and adrenal gland disorders
Ahmad, M., & Bhatia, K. (2017) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2017.06.011 · Cited by 2
Doukhopelnikoff, A., Debrock, G., Steelandt, T., & Jonge, E. T. M. D. (2017) · PubMed Central · Cited by 2
Possible pitfalls in the workup of ectopic ACTH secretion illustrated by four rare cases
Boers, J., Oldenburg-Ligtenberg, P. C., Stades, A. M. E., & van Treijen, M. J. C. (2019) · BMJ Case Reports · doi:10.1136/bcr-2019-231067 · Cited by 2
Suh, J. H., Chao, S. T., & Weil, R. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1637-5.00027-4 · Cited by 4
Bi, W. L., Dunn, I. F., & Laws, E. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00016-0 · Cited by 2
Fahlbusch, R., & Buchfelder, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00024-6 · Cited by 2
Self-citationNadezhdina, E. Y., Rebrova, O. Y., & Grigoriev, A. Y. (2020) · Problems of Endocrinology · doi:10.14341/probl10149 · Cited by 2
Hormone Excess Syndromes of the Hypothalamic-Pituitary Axis
Agrawal, N., Kim, H. H., Wright, K. E., & Mehta, S. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-62187-2_10 · Cited by 3
Pediatric Cushing's disease: Case reports and retrospective review
Pomahačová, R., Paterová, P., Nykodýmová, E., Sýkora, J., & Kršek, M. (2022) · Biomedical Papers · doi:10.5507/bp.2022.049 · Cited by 3
Mamelak, A. N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00007-x · Cited by 2
Adrenocortical carcinoma in a 10-month-old infant: A literature review and a rare case report
Al-Ghotani, B., Alabdallah, E., Shaaban, V., Nemer, F., Alsneeh, A., Sharif, F. A., Dalati, H., & Mansour, M. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000447 · Cited by 2
Case Report: Opposite Tumoral and Hormonal Responses to Low-dose Pasireotide in Cushing’s Disease
Serban, A. L., Zampetti, B., Saladino, A., Favero, V., Chiodini, I., & Cozzi, R. C. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303260160231020070423 · Cited by 2
Remission after transsphenoidal surgery for Cushing disease
Marko, N. F., & Weil, R. J. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.67 · Cited by 2
“67" language="eng" publish="issue" relation="no"> Cushing disease is caused by hypersecretion of adrenocorticotropic hormone (ACTH) by a pituitary adenoma, which results in excess adrenal production of cortisol, disruption of circadian cortisol fluctuation and loss of the normal feedback mechanism of the hypothalamic–…”
BackgroundTratamiento quirúrgico de los adenomas hipofisarios en el Noroeste Argentino
Villalonga, J. F., & Campero, Á. (2020) · Revista Argentina de Neurocirugía · doi:10.59156/revista.v34i01.19 · Cited by 1
Durankus, N. K., Samancı, Y., Yılmaz, M., Şengöz, M., Bölükbaşı, Y., & Peker, S. (2022) · Journal of Neurosurgical Sciences · doi:10.23736/s0390-5616.20.05048-1 · Cited by 1
Ashraf, A., Chernov, I. V., Shkarubo, A. N., Kutin, M. A., Fomichev, D. V., Sharipov, O. I., Trunin, Y. Y., Andreev, D. N., Abdilatipov, A. A., Astafieva, L. I., et al. (2021) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2102-06 · Cited by 1
Noiphithak, R., Nimmannitya, P., Tantongtip, D., Sanpawithayakul, K., Thitiwichienlert, S., Punyarat, P., Rukskul, P., & Yodwisithsak, P. (2021) · Archives of Neuroscience · doi:10.5812/ans.117339 · Cited by 1
Hayek, M. S. E., Choucair, M., & Arabi, A. (2016) · Journal of Endocrinology and Metabolism · doi:10.14740/jem372w · Cited by 1
Development and validation of clinical screening systems for Cushing disease in the United States
Salcedo-Sifuentes, J. E., Mehta, S., Suryadevara, C. M., Bergsneider, M., Yuen, K. C. J., Gardner, P. A., Silverstein, J. M., Kim, A. H., Evans, J. J., Barkhoudarian, G., et al. (2025) · Pituitary · doi:10.1007/s11102-025-01583-4 · Cited by 1
Clinical efficacy and safety of fluconazole treatment in patients with Cushing’s syndrome
Liao, T.-Y., Lin, Y.-C., Huang, C., Hwu, C., & Lin, L. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251372275 · Cited by 1
Krylov, V. V., Usachev, D. Y., Grigoriev, A. Y., Cherebillo, V. Y., Kalinin, P. L., Kutin, M. A., Pashaev, B., Rudenko, P. G., Gormolysova, E., Dedov, I. I., et al. (2026) · Endocrine Surgery · doi:10.14341/serg13053 · Cited by 1
Unklare Gewichtszunahme bei einer 41-jährigen Frau
Harsch, I. A., & Hahn, E. G. (2009) · Der Internist · doi:10.1007/s00108-009-2461-4 · Cited by 1
Pharmacodynamic Evaluation: Endocrinology
Sandow, J. (2010) · Springer eBooks · doi:10.1007/978-3-540-89891-7_35 · Cited by 2
Hypophysenstörungen und sekundärer Diabetes mellitus
Zimmermann, A. G., & Weber, M. (2009) · Der Diabetologe · doi:10.1007/s11428-009-0438-5 · Cited by 1
Alexandraki, K., & Grossman, A. B. (2015) · Cited by 1
Self-citationDiabetes Associated with Glucocorticoid Excess
Janssen, J. A. M. J. L., & Lamberts, S. W. J. (2014) · Frontiers in diabetes · doi:10.1159/000357244 · Cited by 1
Pituitary Tumor Treatment with Somatostatin Analogues
Hubalewska–Dydejczyk, A., Gilis‐Januszewska, A., & Trofimiuk–Müldner, M. (2015) · Wiley eBooks · doi:10.1002/9781119031659.ch16 · Cited by 1
Störungen der Nebennierenfunktion
Partsch, C., & Riepe, F. G. (2014) · Springer eBooks · doi:10.1007/978-3-642-41866-2_65 · Cited by 1
Diagnostics of Cushing's disease in the children (a literature review)
Udalova, N. (2011) · Problems of Endocrinology · doi:10.14341/probl201157557-62 · Cited by 1
Medicamental treatment of Itsenko-Cushing’s disease. The current state-of-the art
Mel'nichenko, G. A., Popovich, V., Rozhinskaya, L. Y., & Belaya, Z. E. (2014) · Problems of Endocrinology · doi:10.14341/probl201460629-37 · Cited by 1
Medical management of Cushing’s syndrome
Morgan, F. H., & Laufgraben, M. J. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.13.3 · Cited by 1
New prospects for drug treatment in Cushing disease
Barahona, M. J., & Picó, C. D. P. (2012) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.07.009 · Cited by 1
Shimon, I., Manisterski, Y., & Kanner, A. A. (2011) · Pituitary · doi:10.1007/s11102-011-0315-2 · Cited by 1
“The remission rate in patients harboring microadenomas undergoing selective adenomectomy is 65–90% [3–5], whereas surgical success rate is much lower in patients with large and invasive macroadenomas [2].”
BackgroundSurgical Approaches to Cushing's Disease
Smith, P. W., & Hanks, J. B. (2011) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2011.06.006 · Cited by 1
Cushing’s Syndrome From Pituitary Microadenoma and Pulmonary Nodules
Tating, D. L. R. P., Montevirgen, N. D. S., & Cajucom, L. A. N. (2016) · Oncology nursing forum · doi:10.1188/16.onf.136-140 · Cited by 1
“Post-surgery, patients need cortisol replacement because of the lack of recovery of the HPA (Biller et al., 2008).”
ACTH-producing tumors of the chest: features of clinical course, diagnosis and surgical treatment
Dobreva, E. A., Krylov, V. V., Kuznetsov, N. S., Паршин, В. В., & Ippolitov, L. I. (2015) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia20158245-51 · Cited by 1
Cushing Disease: A Contemporary Review
Pennacchietti, V., Oyesiku, N. M., & Ioachimescu, A. G. (2015) · Contemporary Neurosurgery · doi:10.1097/01.cne.0000473347.20843.c8 · Cited by 1
Severe hepatocytolisis syndrome - a challenge in medical therapy of Cushing’s disease
Valea, A., Carşote, M., Ghemigian, A. M., Morar, A., Dumitru, D. P., & Georgescu, C. E. (2015) · Ars medica tomitana · doi:10.1515/arsm-2015-0034 · Cited by 1
Surgical Treatment of Cushing’s Disease
Laws, E. R., & Jane, J. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804340-0.00006-1 · Cited by 1
Nieman, L. K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00234-7 · Cited by 1
Self-citationMolitch, M. E. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00231-1 · Cited by 1
Transsphenoidal Surgery for Cushing’s Disease
Post, K. D., Pain, M., Zarzour, H. K., & Bederson, J. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-56691-7_24 · Cited by 1
Treatment for Functioning Pituitary Adenomas
Kurosaki, M. (2018) · Japanese Journal of Neurosurgery · doi:10.7887/jcns.27.449 · Cited by 1
Lirov, R., & Gauger, P. G. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_26 · Cited by 1
Optical Imaging Technology: A Useful Tool to Identify Remission in Cushing Disease After Surgery
Afshari, A., Keil, M. F., Lyssikatos, C., Belyavskaya, E., Valdés, N., Chowdhry, F. A., Parsa, K., Ardeshirpour, Y., Pursley, R. H., Khare, S. M., et al. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0801-8917 · Cited by 2
“At present, cortisol levels are monitored after surgery, but fail to predict long term cure accurately [22, 23, 26].”
BackgroundLania, A. G. (2019) · L Endocrinologo · doi:10.1007/s40619-019-00621-1 · Cited by 1
Endoscopic Endonasal Excision of Pituitary Tumors Using a Mono-nostril Technique
AZIZ, A., DIN, Y.-U., Ahmed, Z. A., RIZVI, S., Sultan, H., CHAUDHRY, A., & MASOOD, R. (2019) · Pakistan Journal Of Neurological Surgery · doi:10.36552/pjns.v23i4.382 · Cited by 1
Idriyani, N., Sumiati, N. T., Febrayosi, P., & Solicha, S. (2020) · International Conference on Religion and Mental Health (ICRMH) · doi:10.4108/eai.18-9-2019.2293363 · Cited by 1
Иващенко, О. В., Grigoriev, A. Y., Неронович, А. В., Nadezhdina, E. Y., Rebrova, O. Y., Лапшина, А. М., & Kolesnikova, G. S. (2020) · Russian journal of neurosurgery · doi:10.17650/1683-3295-2020-22-1-39-48 · Cited by 1
Munir, A., & Newell-Price, J. D. C. (2009) · Medicine · doi:10.1016/j.mpmed.2009.05.013 · Cited by 2
Self-citation
Metadata
- Authors
- Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., Klibanski, A., Lacroix, A., Lindsay, J. R., Newell-Price, J., Nieman, L. K., Petersenn, S., Sonino, N., Stalla, G. K., Swearingen, B., Vance, M. L., Wass, J. A. H., & Boscaro, M.
- Affiliations
- Massachusetts General Hospital (US)
- St Bartholomew's Hospital (GB)
- Queen Elizabeth Hospital Birmingham (GB)
- Cedars-Sinai Medical Center (US)
- Hôpital Cochin (FR)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Naples Federico II (IT)
- Radboud University Nijmegen (NL)
- Erasmus MC (NL)
- Centre Hospitalier de l’Université de Montréal (CA)
- Altnagelvin Area Hospital (GB)
- University of Sheffield (GB)
- National Institutes of Health (US)
- University of Duisburg-Essen (DE)
- University of Padua (IT)
- Max Planck Institute of Psychiatry (DE)
- University of Virginia Health System (US)
- Churchill Hospital (GB)
- Marche Polytechnic University (IT)
- Corresponding author
- Boscaro, M.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-07-01
- Volume
- 93
- Issue
- 7
- Pages
- 2454-2462
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3214276
- OpenAlex
- W2147573461
- Cited by
- 853
- References
- 107
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 26 · 2023: 29 · 2022: 40 · 2021: 35 · 2020: 47 · 2019: 59 · 2018: 42 · 2017: 40 · 2016: 44 · 2015: 91 · 2014: 69 · 2013: 74 · 2012: 70
- FWCI
- 38.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Radboud Repository (Radboud University) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Max Planck Institute for Plasma Physics (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (Z01HD008833)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- ACTH-dependent Cushing's syndrome, Cushing's disease, ectopic ACTH syndrome, Nelson's syndrome, transsphenoidal surgery, pituitary tumor resection, radiotherapy, medical therapy, bilateral adrenalectomy, remission criteria, consensus statement
- MeSH terms
- ACTH Syndrome, Ectopic, Adrenal Insufficiency, Adrenalectomy, Adrenocorticotropic Hormone, Cushing Syndrome, Humans, Hypophysectomy, Metyrapone, Mitotane, Nelson Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.